Age-related macular degeneration: Linking clinical presentation to pathology

Optometry and Vision Science

Volumn 91, Issue 8, 2014, Pages 832-848

  Nivison Smith, Lisa ^a   Milston, Rebecca ^a   Madigan, Michele ^a   Kalloniatis, Michael ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

AMD; Imaging; Macula; Retinal degeneration

Indexed keywords

BIOLOGY; IMAGING TECHNIQUES; KNOWLEDGE BASED SYSTEMS; OPTICAL TOMOGRAPHY; PATHOLOGY;

AGE-RELATED MACULAR DEGENERATION; AMD; CLINICAL ASSESSMENTS; CLINICAL PRESENTATIONS; INFRARED REFLECTANCE; MACULA; NON-INVASIVE IMAGING; RETINAL DEGENERATIONS;

OPHTHALMOLOGY;

CLASSIFICATION; DIAGNOSTIC IMAGING; DRUSEN; EXUDATIVE MACULAR DEGENERATION; GEOGRAPHIC ATROPHY; HUMAN; METHODOLOGY; PATHOLOGY; REVIEW;

DIAGNOSTIC IMAGING; GEOGRAPHIC ATROPHY; HUMANS; RETINAL DRUSEN; WET MACULAR DEGENERATION;

EID: 84905111646     PISSN: 10405488     EISSN: 15389235     Source Type: Journal    
DOI: 10.1097/OPX.0000000000000281     Document Type: Review

References (95)

1. Klein R, Klein BE, KnudtsonMD, Meuer SM, SwiftM, Gangnon RE. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 2007; 114: 253-62.
2. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age- Related Eye Disease Study Report Number 6. Am J Ophthalmol 2001; 132: 668-81.
3. Ferris FL, 3rd, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, Sadda SR. Clinical classification of age-related macular degeneration. Ophthalmology 2013; 120: 844-51.
4. Curcio CA, Messinger JD, Sloan KR, McGwin G, Medeiros NE, Spaide RF. Subretinal drusenoid deposits in non-neovascular agerelated macular degeneration: morphology, prevalence, topography, and biogenesis model. Retina 2013; 33: 265-76.
5. Zweifel SA, Spaide RF, Curcio CA, Malek G, Imamura Y. Reticular pseudodrusen are subretinal drusenoid deposits. Ophthalmology 2010; 117: 303-12.e1.
6. Sarks JP, Sarks SH, Killingsworth MC. Evolution of geographic atrophy of the retinal pigment epithelium. Eye (Lond) 1988; 2 (Pt. 5): 552-77.
7. VotrubaM, Gregor Z. Neovascular age-related macular degeneration: present and future treatment options. Eye (Lond) 2001; 15: 424-9.
8. Mitchell J, Bradley C. Quality of life in age-related macular degeneration: a review of the literature. Health Qual Life Outcomes 2006; 4: 97.
9. Sarks SH. Ageing and degeneration in the macular region: a clinicopathological study. Br J Ophthalmol 1976; 60: 324-41.
10. Elizabeth Rakoczy P, Yu MJ, Nusinowitz S, Chang B, Heckenlively JR. Mouse models of age-related macular degeneration. Exp Eye Res 2006; 82: 741-52.
11. Menon G, Walters G. New paradigms in the treatment of wet AMD: the impact of anti-VEGF therapy. Eye (Lond) 2009; 23 (Suppl 1): S1-7.
12. Muen WJ, Hewick SA. Quality of optometry referrals to neovascular age-related macular degeneration clinic: a prospective study. JRSM Short Rep 2011; 2: 64.
13. Klein R. Overview of progress in the epidemiology of age-related macular degeneration. Ophthalmic Epidemiol 2007; 14: 184-7.
14. SmithW, Mitchell P, Leeder SR. Smoking and age-related maculopathy. The BlueMountains Eye Study. ArchOphthalmol 1996; 114: 1518-23.
15. Klein R, Knudtson MD, Cruickshanks KJ, Klein BE. Further observations on the association between smoking and the long-term incidence and progression of age-related macular degeneration: the Beaver Dam Eye Study. Arch Ophthalmol 2008; 126: 115-21.
16. Khan JC, Thurlby DA, Shahid H, Clayton DG, Yates JR, Bradley M, Moore AT, Bird AC. Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol 2006; 90: 75-80.
17. Seddon JM, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. ArchOphthalmol 2003; 121: 785-92.
18. Hogg RE, Woodside JV, Gilchrist SE, Graydon R, Fletcher AE, Chan W, Knox A, Cartmill B, Chakravarthy U. Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. Ophthalmology 2008; 115: 1046-52.e2.
19. Klein R, Cruickshanks KJ, Myers CE, Sivakumaran TA, Iyengar SK, Meuer SM, Schubert CR, Gangnon RE, Klein BE. The relationship of atherosclerosis to the 10-year cumulative incidence of age-related macular degeneration: the Beaver Dam studies. Ophthalmology 2013; 120: 1012-9.
20. SanGiovanni JP, Chew EY, Clemons TE, Ferris FL, 3rd, Gensler G, Lindblad AS, Milton RC, Seddon JM, Sperduto RD. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. Arch Ophthalmol 2007; 125: 1225-32.
21. Tomany SC, Cruickshanks KJ, Klein R, Klein BE, Knudtson MD. Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol 2004; 122: 750-7.
22. Miller JW. Age-related macular degeneration revisitedVpiecing the puzzle: the LXIX Edward Jackson memorial lecture. Am J Ophthalmol 2013; 155: 1-35.e13.
23. Thakkinstian A, Han P, McEvoyM, Smith W, Hoh J, Magnusson K, ZhangK, Attia J. Systematic review andmeta-analysis of the association between complement factorHY402Hpolymorphisms and age-related macular degeneration. Hum Mol Genet 2006; 15: 2784-90.
24. DeAngelis MM, Ji F, Kim IK, Adams S, Capone A, Jr, Ott J, Miller JW, Dryja TP. Cigarette smoking, CFH, APOE, ELOVL4, and risk of neovascular age-related macular degeneration. Arch Ophthalmol 2007; 125: 49-54.
25. Buitendijk GH, Rochtchina E, Myers C, van Duijn CM, Lee KE, Klein BE, Meuer SM, de Jong PT, Holliday EG, Tan AG, Uitterlinden AG, Sivakumaran TS, Attia J, Hofman A, Mitchell P, Vingerling JR, Iyengar SK, Janssens AC, Wang JJ, Klein R, Klaver CC. Prediction of Age-related Macular Degeneration in the General Population: The Three Continent AMD Consortium. Ophthalmology 2013; 120: 2644-55.
26. Ramrattan RS, van der Schaft TL, Mooy CM, de Bruijn WC, Mulder PG, de Jong PT. Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. Invest Ophthalmol Vis Sci 1994; 35: 2857-64.
27. Kolb H. Simple Anatomy of the Retina. In: Kolb H, Fernandez E, Nelson R, eds. Webvision: The Organization of the Retina and Visual System. Available at: http: //webvision.med.utah.edu/book/part-i-foundations/simple-anatomy-of-the- retina/. Accessed April 4, 2014.
28. Spaide RF, Curcio CA. Anatomical correlates to the bands seen in the outer retina by optical coherence tomography: literature review and model. Retina 2011; 31: 1609-19.
29. Snodderly DM, Brown PK, Delori FC, Auran JD. The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 1984; 25: 660-73.
30. Hendrickson AE, Yuodelis C. The morphological development of the human fovea. Ophthalmology 1984; 91: 603-12.
31. Masland RH. The fundamental plan of the retina. Nat Neurosci 2001; 4: 877-86.
32. Jonas JB, Schneider U, Naumann GO. Count and density of human retinal photoreceptors. Graefes Arch Clin Exp Ophthalmol 1992; 230: 505-10.
33. Curcio CA, Sloan KR, Kalina RE, Hendrickson AE. Human photoreceptor topography. J Comp Neurol 1990; 292: 497-523.
34. Bressler NM, Silva JC, Bressler SB, Fine SL, Green WR. Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. Retina 1994; 14: 130-42.
35. Curcio CA, Millican CL. Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch Ophthalmol 1999; 117: 329-39.
36. Haimovici R, Gantz DL, Rumelt S, Freddo TF, Small DM. The lipid composition of drusen, Bruch's membrane, and sclera by hot stage polarizing light microscopy. Invest Ophthalmol Vis Sci 2001; 42: 1592-9.
37. Curcio CA, Presley JB, Malek G, Medeiros NE, Avery DV, Kruth HS. Esterified and unesterified cholesterol in drusen and basal deposits of eyes with age-related maculopathy. Exp Eye Res 2005; 81: 731-41.
38. Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H, Kamei M, Hasan A, Yan L, Rayborn ME, Salomon RG, Hollyfield JG. Drusen proteome analysis: an approach to the etiology of agerelated macular degeneration. Proc Natl Acad Sci U S A 2002; 99: 14682-7.
39. Mullins RF, Hageman GS. Human ocular drusen possess novel core domains with a distinct carbohydrate composition. J Histochem Cytochem 1999; 47: 1533-40.
40. Moore DJ, Hussain AA, Marshall J. Age-related variation in the hydraulic conductivity of Bruch's membrane. Invest Ophthalmol Vis Sci 1995; 36: 1290-7.
41. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 2001; 20: 705-32.
42. Curcio CA, Johnson M, Rudolf M, Huang JD. The oil spill in ageing Bruch membrane. Br J Ophthalmol 2011; 95: 1638-45.
43. Penfold PL, Madigan MC, Gillies MC, Provis JM. Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res 2001; 20: 385-414.
44. Edwards AO, Ritter R, 3rd, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science 2005; 308: 421-4.
45. Kew RR, Ghebrehiwet B, Janoff A. Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement. J Clin Invest 1985; 75: 1000-7.
46. Morohoshi K, Goodwin AM, Ohbayashi M, Ono SJ. Autoimmunity in retinal degeneration: autoimmune retinopathy and age-related macular degeneration. J Autoimmun 2009; 33: 247-54.
47. Shirinifard A, Glazier JA, Swat M, Gens JS, Family F, Jiang Y, Grossniklaus HE. Adhesion failures determine the pattern of choroidal neovascularization in the eye: a computer simulation study. PLoS Comput Biol 2012; 8: e1002440.
48. Hollyfield JG, Bonilha VL, Rayborn ME, Yang X, Shadrach KG, Lu L, Ufret RL, Salomon RG, Perez VL. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med 2008; 14: 194-8.
49. Lee MY, Yoon J, Ham DI. Clinical features of reticular pseudodrusen according to the fundus distribution. Br J Ophthalmol 2012; 96: 1222-6.
50. De Bats F, Wolff B, Mauget-Faysse M, Meunier I, Denis P, Kodjikian L. Association of reticular pseudodrusen and early onset drusen. ISRN Ophthalmol 2013; 2013: 273085.
51. Rudolf M, Malek G, Messinger JD, Clark ME, Wang L, Curcio CA. Sub-retinal drusenoid deposits in human retina: organization and composition. Exp Eye Res 2008; 87: 402-8.
52. Curcio CA, Medeiros NE, Millican CL. Photoreceptor loss in agerelated macular degeneration. Invest Ophthalmol Vis Sci 1996; 37: 1236-49.
53. Curcio CA, Medeiros NE, Millican CL. The Alabama Age-Related Macular Degeneration Grading System for donor eyes. Invest Ophthalmol Vis Sci 1998; 39: 1085-96.
54. Owsley C, Jackson GR, Cideciyan AV, Huang Y, Fine SL, Ho AC, Maguire MG, Lolley V, Jacobson SG. Psychophysical evidence for rod vulnerability in age-related macular degeneration. Invest Ophthalmol Vis Sci 2000; 41: 267-73.
55. Brown B, Adams AJ, Coletta NJ, Haegerstrom-Portnoy G. Dark adaptation in age-related maculopathy. Ophthalmic Physiol Opt 1986; 6: 81-4.
56. Dimitrov PN, Robman LD, Varsamidis M, Aung KZ, Makeyeva G, Busija L, Vingrys AJ, Guymer RH. Relationship between clinical macular changes and retinal function in age-related macular degeneration. Invest Ophthalmol Vis Sci 2012; 53: 5213-20.
57. Feigl B, Brown B, Lovie-Kitchin J, Swann P. Adaptation responses in early age-related maculopathy. Invest Ophthalmol Vis Sci 2005; 46: 4722-7.
58. Reznicek L, Wasfy T, Stumpf C, Kampik A, Ulbig M, Neubauer AS, Kernt M. Peripheral fundus autofluorescence is increased in agerelated macular degeneration. Invest Ophthalmol Vis Sci 2012; 53: 2193-8.
59. Mimoun G, Soubrane G, Coscas G. [Macular drusen]. J Fr Ophtalmol 1990; 13: 511-30.
60. Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Hope-Ross M, Orlock DR. Digital indocyanine-green videoangiography of occult choroidal neovascularization. Ophthalmology 1994; 101: 1727-35.
61. Chang AA, Guyer DR, Orlock DR, Yannuzzi LA. Age-dependent variations in the drusen fluorescence on indocyanine green angiography. Clin Experiment Ophthalmol 2003; 31: 300-4.
62. Delori FC, Dorey CK, Staurenghi G, Arend O, Goger DG, Weiter JJ. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci 1995; 36: 718-29.
63. Holz FG, Bindewald-Wittich A, Fleckenstein M, Dreyhaupt J, Scholl HP, Schmitz-Valckenberg S, FAM-Study Group. Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am J Ophthalmol 2007; 143: 463-72.
64. Rossberger S, Ach T, Best G, Cremer C, Heintzmann R, Dithmar S. High-resolution imaging of autofluorescent particles within drusen using structured illumination microscopy. Br J Ophthalmol 2013; 97: 518-23.
65. Hartnett ME, Elsner AE. Characteristics of exudative age-related macular degeneration determined in vivo with confocal and indirect infrared imaging. Ophthalmology 1996; 103: 58-71.
66. Diniz B, Ribeiro RM, Rodger DC, Maia M, Sadda S. Drusen detection by confocal aperture-modulated infrared scanning laser ophthalmoscopy. Br J Ophthalmol 2013; 97: 285-90.
67. Spaide RF, Curcio CA. Drusen characterization with multimodal imaging. Retina 2010; 30: 1441-54.
68. Malamos P, Sacu S, Georgopoulos M, Kiss C, Pruente C, Schmidt- Erfurth U. Correlation of high-definition optical coherence tomography and fluorescein angiography imaging in neovascular macular degeneration. Invest Ophthalmol Vis Sci 2009; 50: 4926-33.
69. van Velthoven ME, de Smet MD, Schlingemann RO, Magnani M, Verbraak FD. Added value of OCT in evaluating the presence of leakage in patients with age-related macular degeneration treated with PDT. Graefes Arch Clin Exp Ophthalmol 2006; 244: 1119-23.
70. Fung AE, Lalwani GA, Rosenfeld PJ, Dubovy SR, Michels S, Feuer WJ, Puliafito CA, Davis JL, Flynn HW, Jr, Esquiabro M. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 2007; 143: 566-83.
71. Helb HM, Charbel Issa P, Fleckenstein M, Schmitz-Valckenberg S, Scholl HP, Meyer CH, Eter N, Holz FG. Clinical evaluation of simultaneous confocal scanning laser ophthalmoscopy imaging combined with high-resolution, spectral-domain optical coherence tomography. Acta Ophthalmol 2010; 88: 842-9.
72. Fleckenstein M, Schmitz-Valckenberg S, Adrion C, Kramer I, Eter N, Helb HM, Brinkmann CK, Charbel Issa P, Mansmann U, Holz FG. Tracking progression with spectral-domain optical coherence tomography in geographic atrophy caused by age-related macular degeneration. Invest Ophthalmol Vis Sci 2010; 51: 3846-52.
73. Schmitz-Valckenberg S, Steinberg JS, Fleckenstein M, Visvalingam S, Brinkmann CK, Holz FG. Combined confocal scanning laser ophthalmoscopy and spectral-domain optical coherence tomography imaging of reticular drusen associated with age-related macular degeneration. Ophthalmology 2010; 117: 1169-76.
74. Delori FC, Fleckner MR, Goger DG, Weiter JJ, Dorey CK. Autofluorescence distribution associated with drusen in age-related macular degeneration. Invest Ophthalmol Vis Sci 2000; 41: 496-504.
75. Bindewald A, Bird AC, Dandekar SS, Dolar-Szczasny J, Dreyhaupt J, Fitzke FW, Einbock W, Holz FG, Jorzik JJ, Keilhauer C, Lois N, Mlynski J, Pauleikhoff D, Staurenghi G, Wolf S. Classification of fundus autofluorescence patterns in early age-related macular disease. Invest Ophthalmol Vis Sci 2005; 46: 3309-14.
76. Al-Hussaini H, Schneiders M, Lundh P, Jeffery G. Drusen are associated with local and distant disruptions to human retinal pigment epithelium cells. Exp Eye Res 2009; 88: 610-2.
77. Rudolf M, Clark ME, Chimento MF, Li CM, Medeiros NE, Curcio CA. Prevalence and morphology of druse types in the macula and periphery of eyes with age-related maculopathy. Invest Ophthalmol Vis Sci 2008; 49: 1200-9.
78. Ferris FL, Davis MD, Clemons TE, Lee LY, Chew EY, Lindblad AS, Milton RC, Bressler SB, Klein R, Age-Related Eye Disease Study Research G. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol 2005; 123: 1570-4.
79. Gass JD, Jallow S, Davis B. Adult vitelliform macular detachment occurring in patients with basal laminar drusen. Am J Ophthalmol 1985; 99: 445-59.
80. Leng T, Rosenfeld PJ, Gregori G, Puliafito CA, Punjabi OS. Spectral domain optical coherence tomography characteristics of cuticular drusen. Retina 2009; 29: 988-93.
81. CJ van de Ven JP, Hoyng CB, den Hollander AI, Klevering BJ. Cuticular drusen: stars in the sky. Prog Retin Eye Res 2013; 37: 90-113.
82. Querques G, Canoui-Poitrine F, Coscas F, Massamba N, Querques L, Mimoun G, Bandello F, Souied EH. Analysis of progression of reticular pseudodrusen by spectral domain-optical coherence tomography. Invest Ophthalmol Vis Sci 2012; 53: 1264-70.
83. Ho J, Witkin AJ, Liu J, Chen Y, Fujimoto JG, Schuman JS, Duker JS. Documentation of intraretinal retinal pigment epithelium migration via high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology 2011; 118: 687-93.
84. Christenbury JG, Folgar FA, O'Connell RV, Chiu SJ, Farsiu S, Toth CA. Progression of intermediate age-related macular degeneration with proliferation and inner retinal migration of hyperreflective foci. Ophthalmology 2013; 120: 1038-45.
85. Schmitz-Valckenberg S, Bindewald-Wittich A, Dolar-Szczasny J, Dreyhaupt J, Wolf S, Scholl HP, Holz FG. Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD. Invest Ophthalmol Vis Sci 2006; 47: 2648-54.
86. Sunness JS, Ziegler MD, Applegate CA. Issues in quantifying atrophic macular disease using retinal autofluorescence. Retina 2006; 26: 666-72.
87. Fleckenstein M, Charbel Issa P, Helb HM, Schmitz-Valckenberg S, Finger RP, Scholl HP, Loeffler KU, Holz FG. High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 2008; 49: 4137-44.
88. Campochiaro PA. Retinal and choroidal neovascularization. J Cell Physiol 2000; 184: 301-10.
89. Chamberlin JA, Bressler NM, Bressler SB, Elman MJ, Murphy RP, Flood TP, Hawkins BS, Maguire MG, Fine SL. The use of fundus photographs and fluorescein angiograms in the identification and treatment of choroidal neovascularization in the Macular Photocoagulation Study. The Macular Photocoagulation Study Group. Ophthalmology 1989; 96: 1526-34.
90. Vujosevic S, Vaclavik V, Bird AC, Leung I, Dandekar S, Peto T. Combined grading for choroidal neovascularisation: colour, fluorescein angiography and autofluorescence images. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1453-60.
91. McBain VA, Townend J, Lois N. Fundus autofluorescence in exudative age-related macular degeneration. Br J Ophthalmol 2007; 91: 491-6.
92. Semoun O, Guigui B, Tick S, Coscas G, Soubrane G, Souied EH. Infrared features of classic choroidal neovascularisation in exudative age-related macular degeneration. Br J Ophthalmol 2009; 93: 182-5.
93. Coscas F, Coscas G, Souied E, Tick S, Soubrane G. Optical coherence tomography identification of occult choroidal neovascularization in age-relatedmacular degeneration. AmJOphthalmol 2007; 144: 592-9.
94. Hughes EH, Khan J, Patel N, Kashani S, Chong NV. In vivo demonstration of the anatomic differences between classic and occult choroidal neovascularization using optical coherence tomography. Am J Ophthalmol 2005; 139: 344-6.
95. Lafaut BA, Bartz-Schmidt KU, Vanden Broecke C, Aisenbrey S, De Laey JJ, Heimann K. Clinicopathological correlation in exudative age related macular degeneration: histological differentiation between classic and occult choroidal neovascularisation. Br J Ophthalmol 2000; 84: 239-43.